Member Info for woody2002

Chelsea I was assuming you had already posted your collection of RNS which I had no interest in scrolling to find. You know exactly what I mean, your comments are not clever or insightful twisting my words doesnt make you look intelligent trust me! You can put as much effort in to try get debates out of people but your opinion has no value. Your another BB personality that craves the attention as a means to voice your opinion. Nobody here needs or cares for it. I invest on the news released by the company and the developments being made... its easy to pick at an early stage biotech as it is a money pit we all know it. Like all the other trolls you just point out the AIM cycle and claim its through your amazing research lol. Give us a break you know nothing more than anyone else. When news of a deal eventually breaks youll dissapear with all the rest. Filtered!

Did you just turn up here and pull that out your @$$? Lol

The spread got wider and put a stop on the SP. But tbh there wasnt many buyers anyway, Just traders making a few quid. I tried dummy sells at +9% and +6% and nobody was buying. Couldnt get a price.

I haven't read your previous RNS collection. Ive read them all previously so I dont need a cynic to give me his interpretation.

Why are any of us here? We enjoy investing. Why would having more wealth change anything?

Italian we are all here to make money regardless of wealth. Maybe stop with the jealous posts eh?

SB regularly posts his intentions to buy and its followed by an RNS not just on GGP. No reason for anyone to doubt what the guy says. unless ur RTC and cant read never mind RTC...

200M shares

Boom. Yo Neilly how are you? :P

Discounted placing is the reason for the drop... everyone should know that?

Id say that's a fair assessment.

Dunno about you guys but I think we might be "in talks"

RNS - 14th June - Since the results were released from the VAL401 trial on 16 January 2018, the development has focussed on commercial areas.  An advisory board of UK Key Opinion Leaders was consulted, addressing the significance of the results obtained and the positioning of VAL401 in the UK and global market.  Advanced conversations have continued with a number of prospective partners with the aim of achieving a partnership, to progress the project appropriately towards eventual patient use.  Further validation of the project is demonstrated by the approval of a second patent in New Zealand - further details re set out below

RNS - 6th Sept - Commercial activity surrounding VAL401 has continued.  Detailed discussions are in progress in respect to a pivotal Phase III Clinical Trial.  Partners external to ValiRx and ValiSeek will have substantial input into the trial design, with first dosing anticipated next year

Chelsea - RNS 25th Sept - Detailed discussions are in progress in respect to a pivotal Phase III Clinical Trial for VAL401.  Partners external to ValiRx and ValiSeek will have substantial input into the trial design, with first dosing anticipated next year.  An Advisory board of UK Key Opinion Leaders expressed confidence in taking VAL401 immediately, alongside standard of care cancer treatment.

I wouldnt take any notice of Align, they are internet trolls. They "deramp" companies on Twitter and are regularly wrong! Seen them look really stupid trolling bluejay only to be embarassed when someone pointed out their complete ignorance to facts.

Neilly you still reading?

Why?

Holding RNS incoming!

You cant put 100k into an ISA though. Also dont pay stamp duty on AIM shares do you?